Preoperative serum CD26 levels: Diagnostic efficiency and predictive value for colorectal cancer

British Journal of Cancer

Volumn 83, Issue 9, 2000, Pages 1139-1146

  Cordero, O J ^a   Ayude, D ^b   Nogueira, M ^a   Rodriguez Berrocal, F J ^b   Cadena, M Paez de la ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

CD26 DPP IV; Colorectal cancer; Diagnosis; Serum CD26; Tumour recurrence

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033760338     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1410     Document Type: Article

References (60)

1. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
2. 1997 Update of recommendations for the use of tumor markers in breast and colorectal cancer
3. Membrane-bound peptidases of lymphocytes: Functional implications
4. Value of α-L-fucosidase activity in the diagnosis of colorectal cancer
5. A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV
6. Human U937 cell surface peptidase activities: Characterization and degradative effect on tumour necrosis factor-α
7. The use of relative operating characteristic (ROC) curves in test performance evaluation
8. Serum YKL-40 and colorectal cancer
9. Present status of serum tumour markers in diagnosis, prognosis and evaluation of therapy
10. Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes
11. Human VCD4 helper T cell activation: Functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family
12. CD26, let it cut or cut it down
13. Binding of the adenosine deaminase to the lymphocyte surface via CD26
14. Colorectal cancer: The bases for a comprehensive follow-up
15. Regulation of the biological activity of glucagon-like peptide 2 by dipeptidyl peptidase IV
16. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells
17. The classification of cancer of the rectum
18. α-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence
19. CD26: A surface protease involved in T-cell activation
20. Serum glycylproline p-nitroanilidase activity in blood cancers
21. Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients
22. Hodgkin's disease: A tumour with disturbed immunological pathways
23. Aberrant glycosylation in tumours and tumour-associated carbohydrate antigens
24. Glycylprolyl beta-naphthylamidase activity in human serum
25. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer
26. Dipeptidyl peptidase IV from human serum: Purification, characterization, and N-terminal amino acid sequence
27. CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation
28. Direct association of adenosine deaminase with a T cell activation antigen CD26
29. Nonparametric estimation from incomplete observations
30. Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumour-bearing animals and in cancer patients
31. Elevated serum dipeptidyl peptidase IV (CD26 EC 3.4.14.5) activity in patients with primary biliary cirrhosis
32. Lower activity of serum peptidases in abstinent alcohol-dependent patients
33. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers
34. Post-secretory processing of regulatory peptides: The pancreatic polypeptide family as a model example
35. Local recurrence after curative resection of colorectal adenocarcinoma
36. Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase IV in the serum of people with oral cancer
37. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase
38. Activated lymphoid cells in human gliomas: Morphofunctional and cytochemical evidence
39. Incidence and patterns of recurrence following curative resection for colorectal carcinoma
40. Impaired interleukin-12 production is associated with a defective anti-tumour response in colorectal cancer
41. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage
42. Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity
43. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: Experimental and clinical evidence
44. Amino-terminal truncation of chemokines by CD26/dipeptidyl peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection
45. Potentiation of the immune response in HIV-1+ individuals
46. Assay of dipeptidyl peptidase IV in serum by fluorimetry of 4-methoxy-2-naphthylamine
47. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties
48. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer
49. Local recurrence after curative resection for colorectal cancer: Frequency, risk factors and treatment
50. Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity
51. Adenosine deaminase complexing protein in cancer studies
52. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma
53. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients
54. Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients
55. Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase
56. Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics - Comparison with healthy non-smokers and smokers and effects of inhaled glucocorticoids
57. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells
58. ECM and cell surface proteolysis: Regulating cellular ecology
59. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer
60. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine